Abstract
Critical sized defects, especially in long bones, pose one of the biggest problems in orthopedic surgery. By definition, these defects do not heal without further treatment. Different therapeutic options range from autologous bone grafts, for example, free vascularized bone grafts, to commercially available bone allografts. Disadvantages of these bone allografts are related to reduced osteogenesis, since they are solely composed of cell-free bone matrix. The purpose of this study was to investigate the cell seeding efficiency of human adipose-derived stem cells (hASCs) on human bone allografts in vitro and furthermore analyze these optimized seeded allografts in a critical sized defect model in vivo. Cancellous human bone allografts were colonized with human ASCs in vitro. Cell seeding efficiency was evaluated by Cell Counting Kit-8 assay. Thereafter, optimized hASC-seeded bone scaffolds were examined in a murine femur defect model, stabilized with the MouseExFix system. Subsequently, x-ray analysis and histology were performed. Examination of cell seeding efficiency revealed an optimum starting population of 84,600 cells per 100 mm3 scaffold. In addition, scaffolds seeded with hASCs showed increased osteogenesis compared with controls. Histological analysis revealed increased remodeling and elevated new bone formation within hASC-seeded scaffolds. Moreover, immunohistochemical stainings revealed increased proliferation, osteogenesis, and angiogenesis. In this study, we systemically optimized cell/volume ratio of two promising components of tissue engineering: hASCs and human bone allografts. These findings may serve as a basis for future translational studies.
Key messages
-
Bone tissue engineering.
-
Mesenchymal stem cells derived from human adipose tissue (hASCs).
-
Optimal cell/volume ratio of cell-seeded scaffolds.
-
Increased osteogenesis and angiogenesis in vivo.
Similar content being viewed by others
Abbreviations
- hASC :
-
human adipose stem cell
- DMEM :
-
Dulbecco’s Modified Eagle Medium
- FCS :
-
fetal calf serum
- DIZG :
-
Deutsches Institut für Zell- und Gewebeersatz
- CCK-8 :
-
cell counting kit 8
- PBS :
-
phosphate buffered saline
- EDTA :
-
Ethylenediamine-tetraacetate
- PCNA :
-
Proliferating-Cell-Nuclear-Antigen
- RUNX2 :
-
Runt-related transcription factor
- DAPI :
-
4,6-diamidino-2-phenylindole
- Tunel :
-
TdT-mediated dUTP-biotin nick end labeling
- hmito :
-
human mitochondrias
- HIV :
-
human immunodeficiency virus
- VEGF :
-
vascular endothelial growth factor
- TCP:
-
tricalcium-phosphate
- SVF :
-
stromal vascular fraction
References
Marelli B, Ghezzi CE, Mohn D, Stark WJ, Barralet JE, Boccaccini AR, Nazhat SN (2011) Accelerated mineralization of dense collagen-nano bioactive glass hybrid gels increases scaffold stiffness and regulates osteoblastic function. Biomaterials 32:8915–8926
Zhao L, Weir MD, Xu HH (2010) Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 31:3848–3857
Cai L, Wang Q, Gu C, Wu J, Wang J, Kang N, Hu J, Xie F, Yan L, Liu X, Cao Y, Xiao R (2011) Vascular and micro-environmental influences on MSC-coral hydroxyapatite construct-based bone tissue engineering. Biomaterials 32:8497–8505
Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R (2000) Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 21:1803–1810
Huang Y, Jin X, Zhang X, Sun H, Tu J, Tang T, Chang J, Dai K (2009) In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 30:5041–5048
Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR (2006) Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27:3413–3431
Fu S, Ni P, Wang B, Chu B, Zheng L, Luo F, Luo J, Qian Z (2012) Injectable and thermo-sensitive PEG-PCL-PEG copolymer/collagen/n-HA hydrogel composite for guided bone regeneration. Biomaterials 33:4801–4809
Drury JL, Mooney DJ (2003) Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24:4337–4351
Mata A, Geng Y, Henrikson KJ, Aparicio C, Stock SR, Satcher RL, Stupp SI (2010) Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix. Biomaterials 31:6004–6012
Bhakta G, Rai B, Lim ZX, Hui JH, Stein GS, van Wijnen AJ, Nurcombe V, Prestwich GD, Cool SM (2012) Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 33:6113–6122
Patterson J, Siew R, Herring SW, Lin AS, Guldberg R, Stayton PS (2010) Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials 31:6772–6781
Jha AK, Xu X, Duncan RL, Jia X (2011) Controlling the adhesion and differentiation of mesenchymal stem cells using hyaluronic acid-based, doubly crosslinked networks. Biomaterials 32:2466–2478
Bae MS, Yang DH, Lee JB, Heo DN, Kwon YD, Youn IC, Choi K, Hong JH, Kim GT, Choi YS, Hwang EH, Kwon IK (2011) Photo-cured hyaluronic acid-based hydrogels containing simvastatin as a bone tissue regeneration scaffold. Biomaterials 32:8161–8171
Kanczler JM, Ginty PJ, White L, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO (2010) The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31:1242–1250
Park SH, Gil ES, Kim HJ, Lee K, Kaplan DL (2010) Relationships between degradability of silk scaffolds and osteogenesis. Biomaterials 31:6162–6172
Bhumiratana S, Grayson WL, Castaneda A, Rockwood DN, Gil ES, Kaplan DL, Vunjak-Novakovic G (2011) Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds. Biomaterials 32:2812–2820
Zhang Y, Wu C, Friis T, Xiao Y (2010) The osteogenic properties of CaP/silk composite scaffolds. Biomaterials 31:2848–2856
Bi L, Cheng W, Fan H, Pei G (2010) Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma. Biomaterials 31:3201–3211
Wang L, Stegemann JP (2010) Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering. Biomaterials 31:3976–3985
Yu HS, Won JE, Jin GZ, Kim HW (2012) Construction of mesenchymal stem cell-containing collagen gel with a macrochanneled polycaprolactone scaffold and the flow perfusion culturing for bone tissue engineering. BioRes open access 1:124–136
Aravamudhan A, Ramos DM, Nip J, Harmon MD, James R, Deng M, Laurencin CT, Yu X, Kumbar SG (2013) Cellulose and collagen derived micro-nano structured scaffolds for bone tissue engineering. J Biomed Nanotechnol 9:719–731
Bueno EM, Glowacki J (2009) Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 5:685–697
Zimmermann G, Wagner C, Schmeckenbecher K, Wentzensen A, Moghaddam A (2009) Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft. Injury 40(Suppl 3):S50–S53
Bertolai R, Catelani C, Aversa A, Rossi A, Giannini D, Bani D (2015) Bone graft and mesenchimal stem cells- clinical observations and histological analysis. Clin Cases Miner Bone Metab 12:183–187
Stevenson S, Li XQ, Martin B (1991) The fate of cancellous and cortical bone after transplantation of fresh and frozen tissue-antigen-matched and mismatched osteochondral allografts in dogs. J Bone Joint Surg Am 73:1143–1156
Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM (2005) The biology of bone grafting. J Am Acad Orthop Surg 13:77–86
Sundelacruz S, Kaplan DL (2009) Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Semin Cell Dev Biol 20:646–655
Romagnoli C, Brandi ML (2014) Adipose mesenchymal stem cells in the field of bone tissue engineering. World journal of stem cells 6:144–152
Kloeters O, Berger I, Ryssel H, Megerle K, Leimer U, Germann G (2011) Revitalization of cortical bone allograft by application of vascularized scaffolds seeded with osteogenic induced adipose tissue derived stem cells in a rabbit model. Arch Orthop Trauma Surg 131:1459–1466
Zwingenberger S, Niederlohmann E, Vater C, Rammelt S, Matthys R, Bernhardt R, Valladares RD, Goodman SB, Stiehler M (2013) Establishment of a femoral critical-size bone defect model in immunodeficient mice. J Surg Res 181:e7–e14
Behr B, Leucht P, Longaker MT, Quarto N (2010) Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. PNAS 107:11853–11858
Wallner C, Schira J, Wagner JM, Schulte M, Fischer S, Hirsch T, Richter W, Abraham S, Kneser U, Lehnhardt M, Behr B (2015) Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration. PLoS One 10:e0118823
Wagner JM, Reinkemeier F, Wallner C, Dadras M, Huber J, Schmidt SV, Drysch M, Dittfeld S, Jaurich H, Becerikli M, Becker K, Rauch N, Duhan V, Lehnhardt M, Behr B (2019) Adipose derived stromal cells (ASCs) are capable to restore bone regeneration after posttraumatic osteomyelitis and modulate B-cell response. Stem Cells Transl Med. https://doi.org/10.1002/sctm.18-0266
Seebach C, Schultheiss J, Wilhelm K, Frank J, Henrich D (2010) Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro. Injury 41:731–738
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211–228
Polo-Corrales L, Latorre-Esteves M, Ramirez-Vick JE (2014) Scaffold design for bone regeneration. J Nanosci Nanotechnol 14:15–56
Seebach C, Henrich D, Wilhelm K, Barker JH, Marzi I (2012) Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats. Cell Transplant 21:1667–1677
Schubert T, Xhema D, Veriter S, Schubert M, Behets C, Delloye C, Gianello P, Dufrane D (2011) The enhanced performance of bone allografts using osteogenic-differentiated adipose-derived mesenchymal stem cells. Biomaterials 32:8880–8891
Morcos MW, Al-Jallad H, Hamdy R (2015) Comprehensive review of adipose stem cells and their implication in distraction osteogenesis and bone regeneration. BioMed research international 2015:842975
Conrad EU, Gretch DR, Obermeyer KR, Moogk MS, Sayers M, Wilson JJ, Strong DM (1995) Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am 77:214–224
Ehrler DM, Vaccaro AR (2000) The use of allograft bone in lumbar spine surgery. Clin Orthop Relat Res 371:38–45
Behr B, Tang C, Germann G, Longaker MT, Quarto N (2011) Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation. Stem Cells 29:286–296
Thesleff T, Lehtimaki K, Niskakangas T, Huovinen S, Mannerstrom B, Miettinen S, Seppanen-Kaijansinkko R, Ohman J (2017) Cranioplasty with adipose-derived stem cells, beta-tricalcium phosphate granules and supporting mesh: six-year clinical follow-up results. Stem Cells Transl Med 6:1576–1582
Saxer F, Scherberich A, Todorov A, Studer P, Miot S, Schreiner S, Guven S, Tchang LA, Haug M, Heberer M et al (2016) Implantation of stromal vascular fraction progenitors at bone fracture sites: from a rat model to a first-in-man study. Stem Cells 34:2956–2966
Veriter S, Andre W, Aouassar N, Poirel HA, Lafosse A, Docquier PL, Dufrane D (2015) Human adipose-derived mesenchymal stem cells in cell therapy: safety and feasibility in different “hospital exemption” clinical applications. PLoS One 10:e0139566
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experiments were performed in adherence to the National Institute of Health guidelines for the use of experimental animals and after approval by the German legislation. The protocol was approved by the LANUV (NRW, Germany; Permit-Number: AZ 84-02.04.2013.A362).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PNG 118 kb)
Rights and permissions
About this article
Cite this article
Wagner, J.M., Conze, N., Lewik, G. et al. Bone allografts combined with adipose-derived stem cells in an optimized cell/volume ratio showed enhanced osteogenesis and angiogenesis in a murine femur defect model. J Mol Med 97, 1439–1450 (2019). https://doi.org/10.1007/s00109-019-01822-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-019-01822-9